MannKind Corporation (MNKD)
NASDAQ: MNKD · Real-Time Price · USD
5.63
-0.07 (-1.23%)
Nov 7, 2025, 4:00 PM EST - Market closed
MannKind Employees
As of December 31, 2024, MannKind had 407 total employees, including 403 full-time and 4 part-time employees. The number of employees decreased by 7 or -1.69% compared to the previous year.
Employees
407
Change (1Y)
-7
Growth (1Y)
-1.69%
Revenue / Employee
$770,975
Profits / Employee
$71,826
Market Cap
1.73B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 407 | -7 | -1.69% |
| Dec 31, 2023 | 414 | 19 | 4.81% |
| Dec 31, 2022 | 395 | 46 | 13.18% |
| Dec 31, 2021 | 349 | 108 | 44.81% |
| Dec 31, 2020 | 241 | 8 | 3.43% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
MNKD News
- 2 days ago - MannKind Commemorates Alfred E. Mann's 100th Birthday with New Scholarship Program Supporting Young Adults Living with Diabetes - GlobeNewsWire
- 3 days ago - MannKind Corporation (MNKD) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 days ago - MannKind Corporation Reports Third Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 10 days ago - MannKind Corporation to Hold 2025 Third Quarter Financial Results Conference Call on November 5, 2025 - GlobeNewsWire
- 24 days ago - MannKind: Durable Cash Engine, Optional Catalysts Pending - Seeking Alpha
- 26 days ago - MannKind Announces U.S. FDA Accepts for Review its Supplemental Biologics License Application (sBLA) for Inhaled Insulin (Afrezza) in Children and Adolescents Aged 4-17 Years Living with Diabetes - GlobeNewsWire
- 4 weeks ago - MannKind Completes Acquisition of scPharmaceuticals, Accelerating Revenue Growth in Cardiometabolic Care - GlobeNewsWire
- 5 weeks ago - MannKind Appoints Dr. Ajay Ahuja as Executive Vice President and Chief Medical Officer - GlobeNewsWire